Whalesbook
Is funding se Jus' Onco apne innovative healthcare model ko aur accelerate karega. India mein cancer treatment bahut expensive hai aur access bhi mushkil hai.
Yaani, ye company ek 'Collaborative Cancer Care Network' (C3N) model chala rahi hai. Ye bade, mehange hospitals ke chakkar mein nahi padte. Iske bajay, ye efficient operations aur shared clinics use karte hain diagnosis, chemotherapy se lekar surgery tak sabke liye. Is shared-clinic strategy se, Jus' Onco ka claim hai ki ye treatment ka kharcha 50% tak kam kar sakte hain standard corporate hospitals ke comparison mein. Ye model abhi Chennai ke kuch parts mein chal raha hai.
Ab baat karte hain funding ki. Ye paisa mila hai Tamil Nadu Emerging Sector Seed Fund (TNESSF) se, jise TNIFMC manage karta hai. Ye fund Tamil Nadu mein startups ko support karta hai aur usually ₹3 Cr se ₹10 Cr tak invest karta hai tech-focused companies mein. Is funding se Jus' Onco Tamil Nadu ke underserved areas mein expand karega aur har district mein ek cancer care center kholne ka target hai.
India ka oncology market bahut bada ho raha hai, aur iski growth rate 19.8% per annum predict ki ja rahi hai 2024-2029 ke beech. Cancer rates badh rahe hain aur logo ko treatment ke liye bahut paisa kharch karna padta hai. Jus' Onco ka decentralized model seedha issi problem ko solve karne ke liye banaya gaya hai. Bade players jaise Apollo, Fortis hain, par Jus' Onco focus kar raha hai cost-sensitive patients aur underserved populations par.
Haan, challenges bhi hain. Healthcare sector fragmented hai aur regulations complicated hain. Decentralized model ko scale karna bhi tricky hai. Quality maintain karna bhi ek bada kaam hoga. Par funding mil gayi hai, toh ab dekhte hain ye log kaise succeed karte hain.